6th CRC Screening Summit
2025-12-04
The 6th Colorectal Cancer (CRC) Screening Summit, hosted by Digestive Cancers Europe (DiCE), is an online event scheduled for December 4, 2025, from 9:00 AM to 12:30 PM CET. The summit will build upon previous discussions regarding the urgent challenge of early detection and prevention of colorectal cancer, a leading cause of cancer deaths in Europe.
The goal is to collaborate with experts, healthcare professionals, and policymakers to advance effective, accessible, and sustainable screening programs across the continent, driving progress toward better prevention, earlier diagnosis, and improved health outcomes for all European communities.
Register.

Anti-HER2 Therapies: Biological Mechanisms and Toxicity Management
2025-12-04
The event “Anti-HER2 therapies: biological mechanisms and toxicity management“ is a live webinar scheduled for December 4, 2025, at 18:00 CET.
This online educational session is focused on breast cancer and will feature experts who will discuss the molecular mechanisms that underpin HER2-targeted treatments and their role in improving patient outcomes, while also providing a comprehensive and practical overview of the challenges and strategies for managing therapy-related toxicities.
The webinar aims to enhance the knowledge of clinicians and researchers involved in the care of patients with HER2-positive breast cancer.

Pediatric Cardio-Oncology Consortium Virtual Summit
2025-12-04
The Pediatric Cardio-Oncology Consortium (PCOC) Virtual Summit is a complimentary, CME-accredited online event scheduled for December 4, 2025, 10 AM EST, and is jointly sponsored by Cincinnati Children’s Hospital Medical Center, Sofia’s Hope, and the Pediatric Cardiomyopathy Registry, in conjunction with the International Cardio-Oncology Society.
The summit’s goal is to bring together a multidisciplinary group of healthcare professionals to discuss and shape the optimal management of pediatric cardio-oncology. The program is focused on three main sessions: Multi-Modality Imaging Surveillance in pediatric cardio-oncology, Cardiovascular Toxicity in Pediatric Oncology (covering new agents like Tyrosine Kinase Inhibitors and Immunotherapies), and addressing Cardiovascular Disease in Young Adult Survivors.
Register.

7th European Cancer Forum
2025-12-04 | Residence Palace, Brussels, Rue de la Loi 155, Bruxelles (Brussels), Region of Brussels-Capital, 1040, Belgium
The 7th edition of the European Cancer Forum (ECF) on December 4, 2025, will be held under the theme “Innovation, Security and Sustainability: Shaping the Future of Cancer Care,” aiming to ensure that advancements in oncology are not sidelined by the EU’s focus on external challenges.
This high-level policy forum will gather leading policymakers, healthcare professionals, industry experts, and patient advocates to reflect on progress under Europe’s Beating Cancer Plan and strategically align the future of cancer care with the European Union’s broader ambitions for health security, innovation, and long-term sustainable healthcare systems.
Register.

How to Make Sense of Treatment Options for Hepatocellular Carcinoma in 2025
2025-12-04
The OncoWisdom Webinar titled, “How to Make Sense of Treatment Options for Hepatocellular Carcinoma in 2025,” is a free session for oncologists, surgeons, hepatologists, and researchers focusing on liver cancer care. The live, online event is scheduled for December 4, 2025, starting at 6:30 PM IST (Indian Standard Time).
The agenda includes an opening session on Integrating local and systemic therapy in HCC, followed by a panel discussion on current and emerging data, all part of OncoWisdom’s mission to facilitate evidence-based discussions among global experts to elevate cancer care worldwide.
Register.

Exploring the Tumour Immune Landscape: Spatial and Functional Insights
2025-12-04 15:00 - 16:00 (America/Halifax)
The “Exploring the tumour immune landscape: Spatial and functional insights” EACR and 10x Genomics Webinar is a free, virtual event scheduled for December 4, 2025, from 15:00 to 16:00 CET on Zoom.
This educational collaboration between the European Association for Cancer Research (EACR) and 10x Genomics focuses on using advanced technologies to understand the tumor immune microenvironment. The webinar will feature two expert speakers discussing research on spatially resolving antigen receptors in tumor tissue, and the ex vivo modeling of the tumor immune microenvironment in lung cancer to investigate responses to therapies and immune evasion mechanisms.
Register.

Gustave Roussy and Friends Invite 2025
2025-12-05 | Espace Congrès les Esselières, 3 Boulevard Chastenet de Géry, Villejuif, Val-de-Marne, 94800, France
The Gustave Roussy and Friends Invite 2025: Connecting institutions, sharing visions, transforming cancer care will hold its second edition on December 3, 2025, in Paris. The annual event is a dynamic platform for collaboration, bringing together oncological teams and their medical ecosystems to exchange insights on the evolving landscape of cancer treatment and patient care. This edition will honor the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) Heidelberg as distinguished guests, with lectures and discussions focusing on critical topics such as institutional transformation, healthcare organization, research, access to innovative therapies, and the essential role of patient representation.

French Society for Cancer Immunotherapy Highlights Webinar 2025
2025-12-05
The French Society for Cancer Immunotherapy is hosting its Highlights 2025 Webinar – Innovations and Perspectives in Immuno-Oncology, an essential, free educational event scheduled for Friday, December 5, from 12:15 PM to 2:00 PM (live on Teams). The primary focus of the webinar is to showcase the 2025 advances in both clinical and translational research within the dynamic field of immuno-oncology. The event promises a high level of expertise, featuring a prestigious panel of speakers from top French institutions.
Register.

Essential Breast Cancer Medicines
2025-12-05
The Webinar: Essential Breast Cancer Medicines, a free, live, interactive online event organized by ecancer as part of the Grand Rounds in Breast Cancer series, is scheduled for December 5, 2025, at 12:00 GMT / 13:00 CET.
The webinar will feature a panel of global experts, including Dr. Didier Verhoeven (Chair), Prof. Helena Earl, Dr. Emad Shash, and Prof. Luiz Gebrim, to discuss the topic of breast cancer medicines and provide perspectives from different regions worldwide.
Register.

IASLC/ASCO 2025 North America Conference on Lung Cancer
2025-12-05 - 2025-12-07 | Chicago Marriott Downtown Magnificent Mile, 540 North Michigan Avenue, Chicago, IL, 60611, United States
The IASLC/ASCO 2025 North America Conference on Lung Cancer (NACLC 2025) is a major event dedicated to advancing lung cancer care, spotlighting the latest in clinical research, early detection, and breakthrough therapies for thoracic malignancies. The conference is a dynamic in-person experience designed for clinicians, researchers, and advocates to collaborate, discover cutting-edge treatments, and explore strategies to advance equity. It will be held in Chicago from December 5 to December 7, 2025. The NACLC 2025 is jointly organized by IASLC (International Association for the Study of Lung Cancer) and ASCO (American Society of Clinical Oncology).
You can find more posts featuring NACLC25 on OncoDaily.

ESMO Asia Congress 2025
2025-12-05 08:00 - 2025-12-07 17:00 (America/Halifax) | Suntec Singapore Convention & Exhibition Centre, 1 Raffles Boulevard Singapore, Singapore, 039593, Singapore
ESMO Asia Congress 2025 will be held from December 5-7, 2025 at Singapore, Republic of Singapore.
The congress serves as a vital platform to advance cancer care through the latest scientific discoveries, innovative therapies, and evolving clinical practices. Whether you’re a clinician, researcher, or healthcare provider, this gathering offers a front-row seat to the future of oncology.
Congress Officers for ESMO Asia Congress 2025 are Fabrice André, Do-Youn Oh, Sjoukje Oosting, Arun Azad, and Nadia Harbeck.
Attendees can expect a rich and diverse programme featuring plenary lectures, multidisciplinary tumour boards, “Meet the Expert” sessions, and poster presentations, all designed to promote cross-disciplinary learning and collaboration. With a strong emphasis on clinical excellence and global perspectives, ESMO Asia fosters a vibrant exchange of knowledge, helping to shape cancer treatment strategies tailored to the region’s unique challenges.
Mark your calendar for this transformative event in Singapore, where science meets practice to improve patient outcomes.
Registration is Open for The Event.

SITC-ASH Scientific Workshop on Host Factors in Cell and Gene Therapy: Impact on Efficacy and Toxicity
2025-12-05 15:00 - 18:00 (America/Halifax) | Orange County Convention Center, 9860 Universal Blvd, Orlando, FL, 32819-8706, United States
The SITC-ASH Scientific Workshop on Host Factors in Cell and Gene Therapy: Impact on Efficacy and Toxicity is a collaborative scientific workshop organized by the American Society of Hematology (ASH) and the Society for Immunotherapy of Cancer (SITC).
Scheduled for Friday, December 5, 2025, from 3:00–6:00 p.m. ET, the workshop will be held in conjunction with the ASH Annual Meeting at the Orange County Convention Center in Orlando, Florida. The program focuses on how host biology influences the efficacy and toxicity of cell and gene therapies, with expert speakers sharing recent findings and discussing strategies to optimize outcomes for both hematologic and solid tumor applications.
Register.

67th ASH Annual Meeting and Exposition
2025-12-06 - 2025-12-09 | Orange County Convention Center, 9860 Universal Blvd, Orlando, FL, 32819-8706, United States
The 67th ASH Annual Meeting and Exposition, the world’s most comprehensive event in classical and malignant hematology, is scheduled to take place virtually and in-person from December 6–9, 2025. The in-person component will be held at the Orange County Convention Center in Orlando, Florida.
Hosted by the American Society of Hematology, the meeting attracts over 30,000 attendees and features more than 5,000 novel abstracts, providing a world-class educational and networking experience for researchers, clinicians, trainees, and industry professionals. Registration is now open for ASH members, non-members, groups, exhibitors, and media.

ON-COLLAB Brazil - International Workshop on Oncology Research Methods
2025-12-06 - 2025-12-10 | Hotel Fazenda Hípica Atibaia – SP / Brazil, Estrada Guaxinduva, 1145, Atibaia, São Paulo (SP), 12940-000, Brazil
The International Workshop on Oncology Research Methods (ON-COLLAB Brazil) is a five-day, fully funded immersive program organized by the Brazilian Ministry of Health, the University Hospitals Company (EBSERH) and 45 University Hospitals Network.
Taking place December 5-10, 2025, in Atibaia, São Paulo, Brazil, the workshop aims to strengthen research capacity in oncology by connecting national and international experts with early- and mid-career healthcare professionals.
Designed for clinicians, residents, and researchers working in oncology and related fields, ON-COLLAB focuses on developing and refining participants’ clinical and applied research project proposals. Through lectures, hands-on group work, and mentorship from global leaders affiliated with ASCO, EORTC, AORTIC, and Nature Cancer Reviews, attendees will enhance their knowledge in research design, data analysis, and scientific writing.
Participation in the workshop is free of charge, with accommodation and meals provided. A total of 24 professionals will be selected, and notably, one-third of places are reserved for applicants from Portuguese-speaking African countries and Latin America.
Registration runs from October 9-29, 2025, and applicants are encouraged to submit a preliminary oncology research proposal to be refined during the program.
For inquiries, contact on-collab@ebserh.gov.br.

Read more about the event on OncoDaily.

Japan TeamOncology Workshop (4th Team Science Workshop)
2025-12-07 | National Center for Global Health and Medicine, 1-chōme-21-1 Toyama, Shinjuku City, Tokyo, 162-8655, Japan
The Japan TeamOncology Workshop (4th Team Science Workshop) is a two-part educational program focusing on promoting patient-centered, multidisciplinary cancer care.
The first part is an online session via Zoom on Sunday, December 7, 2025, from 8:00 a.m. to 4:30 p.m. (JST).
The second part is an in-person session held over three days: Saturday, January 10, Sunday, January 11, and Monday, January 12, 2026, at the National Center for Global Health and Medicine in Shinjuku-ku, Tokyo, Japan.
The workshop, now in its 24th year, convenes oncology care professionals from Japan and across Asia to enhance their leadership and communication skills through didactic lectures, interactive small group discussions, and project-based learning (PBL), with a special emphasis on Psychological Safety and Equity, Diversity, and Inclusion.

ESMO Preceptorship on NSCLC and SCLC 2025: Singapore
2025-12-08 - 2025-12-09 | The Orchard Singapore Hotel, 442 Orchard Road, Singapore, 238879, Singapore
The ESMO Preceptorship on NSCLC and SCLC 2025 in Singapore, taking place from 8 December 2025 to 9 December 2025, brings together oncology professionals to explore best practices in managing non-small-cell and small-cell lung cancer across all stages.
The programme covers the latest in targeted therapies, actionable driver alterations, immune checkpoint blockade, novel immunotherapies, and systemic treatment of SCLC and pleural mesothelioma. Accredited with 10 ESMO-MORA category 1 points, the preceptorship offers participants hands-on learning, expert insights, and a travel grant for non-local attendees to support participation.

San Antonio Breast Cancer Symposium (SABCS) 2025
2025-12-09 - 2025-12-12 | SABCS, Henry B. González Convention Center, 900 E. Market Street, San Antonio, Texas 78205, San Antonio, TX, 78205, United States
The San Antonio Breast Cancer Symposium (SABCS) 2025 will be held from December 9–12, 2025, at the Henry B. González Convention Center in San Antonio, Texas, USA. Recognized globally as one of the leading conferences in breast cancer research and treatment, SABCS provides an unparalleled forum for the presentation and discussion of the latest scientific advances in both experimental biology and clinical care of breast cancer.
The symposium brings together basic scientists, clinicians, and healthcare professionals from around the world to foster collaboration and exchange of knowledge that drives progress in breast cancer prevention, diagnosis, and therapy. With its comprehensive program of plenary lectures, case discussions, and abstract presentations, SABCS 2025 will continue its tradition of promoting excellence and innovation in breast cancer research and patient care.
You can find more posts featuring SABCS25 on OncoDaily.

AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers - Knowledge Gaps and Research Opportunities
2025-12-10 - 2025-12-13 | 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106-4404, USA, 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106-4404, USA, Philadelphia, PA, 19106-4404, United States
This AACR Special Conference in Cancer Research will be held December 10–13, 2025, in Montreal, Quebec, Canada.
The meeting is designed as an in-person event, with all presentations delivered live, though the content will later be made available on demand.
The scientific program covers topics such as epidemiology of early-onset cancer, mechanisms (metabolic, exogenous, endogenous), detection and screening, interception strategies, and global disparities in early-onset cancers.
This conference provides a forum for researchers, clinicians, and public health professionals to identify knowledge gaps and research opportunities in the rapidly evolving field of early-onset cancers. The sessions are structured to encourage cross-disciplinary dialogue and to spark ideas that can advance understanding and intervention strategies for cancers manifesting at younger ages.
You can find more posts featuring AACR on OncoDaily.

ESMO Virtual Journal Club: December 2025
2025-12-10
The ESMO Virtual Journal Club: December 2025 is a one-hour virtual educational event exclusively for ESMO Members, scheduled for Wednesday, December 10, 2025, at 18:30 CET.
Chaired by Dr. Anna Campbell, the Journal Club aims to enhance the understanding and application of the latest research in oncology by focusing on and critically evaluating two newly published studies: “Structured Exercise after Adjuvant Chemotherapy in Colon Cancer (CHALLENGE)” and “Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.” Live attendees will receive a certificate of attendance and 1 ESMO-MORA category 1 point.
Register.

Assessing Physical Function in Transplantation and CAR T Recipients
2025-12-10
“Assessing Physical Function in Transplantation and CAR T Recipients” is a free panel-based webinar offered by the ASTCT Survivorship SIG (American Society for Transplantation and Cellular Therapy) and is scheduled for December 10, 2025, at 12:00 PM CST.
The webinar’s focus is on clinical practice and research, aiming to help attendees identify and understand the currently available physical assessment tools for evaluating physical function in patients before, during, and after receiving hematopoietic cell transplantation (HCT) or CAR T-cell therapies. The expert panel includes speakers such as Shatha Farhan, MD, and Shernan Holtan, MD, and the goal is to bridge knowledge gaps and encourage the optimized use of these tools in clinical practice.
Register.

Flash Radiotherapy and Particle Therapy 2025 Conference
2025-12-10 - 2025-12-12 | Clarion Congress Hotel Prague, Freyova 945/33, Prague, Hlavni mesto Praha, 190 00, Czech Republic
The FRPT (Flash Radiotherapy and Particle Therapy) 2025 Conference is a major multidisciplinary forum dedicated to uniting cutting-edge radiation therapies with groundbreaking research and clinical trials. The conference is scheduled for December 10–12, 2025, and will be held in Prague, the Czech Republic. Over three days, the event will showcase the latest updates on FLASH and particle therapy across basic science, preclinical research, clinical trials, and treatment, bringing together leading researchers, clinicians, industry providers, and an international audience.

AOFOG-ASGO Gynecologic Oncology Research Workshop
2025-12-10 - 2025-12-13 | Hong Kong SkyCity Marriott Hotel, International Airport, 1 Sky City Rd E, Lantau Island, Hong Kong, China
The AOFOG-ASGO Gynecologic Oncology Research Workshop (AGORE) is scheduled for December 10–13, 2025, and will be held at the Skycity Marriott in Hong Kong.
This event is specifically designed for gynecological oncology fellows and oncologists, offering a unique opportunity to enhance their research skills through a program featuring engaging lectures, mentoring sessions, and hands-on workshops, with the goal of advancing research expertise in the field.
Register.

ESMO Immuno-Oncology Congress 2025
2025-12-10 08:00 - 2025-12-12 17:00 (Europe/London) | Queen Elizabeth II Centre in London, United Kingdom, Broad Sanctuary, London SW1P 3EE, London, United Kingdom
The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event, both onsite in London, UK, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect cutting-edge sessions, in-depth learning opportunities, and dynamic networking with peers, researchers, and industry leaders.
The programme includes immersion sessions focused on immunobiology and translational insights, updates on checkpoint inhibitor-based therapies, and the latest in immune modulation including tumour microenvironment, immunometabolism, and cell signaling. Participants will also engage with industry and independent investigators to explore developments in cellular therapies, cancer vaccines, intratumoural immunotherapy, and multispecific constructs.
Whether attending in person or online, the congress offers a valuable platform to share research, expand knowledge, and shape the future of cancer immunotherapy.
Registration is Open for the Event.
More posts featuring ESMO.

ESMO-IO SITC Primer Program
2025-12-10 08:30 - 12:00 (America/Halifax) | Queen Elizabeth II Centre in London, United Kingdom, Broad Sanctuary, London SW1P 3EE, London, United Kingdom
The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC), scheduled for December 10, 2025, from 8:30 a.m. to 12:00 p.m. BST.
This half-day primer, held at the Queen Elizabeth II Centre in London, UK, focuses on fundamental immuno-oncology (IO) concepts.
The program will cover current and emerging topics in immuno-oncology (IO), including neoadjuvant immunotherapy, intratumoral immunotherapies, recombinant cytokines, and bispecific antibodies, alongside new applications of AI, spatial biology, and multiomic approaches.

The Role of Modern Radiotherapy for Low Grade Glioma
2025-12-11
The educational webinar titled “The Role of Modern Radiotherapy for Low Grade Glioma,” part of the Educational Lectures on Paediatric Radiation Oncology Series, will be held virtually on December 11, 2025, at 16:00 CET (Central European Time).
This open-to-all session will feature speaker Danny Indelicato, Professor in the Department of Radiation Oncology at the University of Florida. The webinar will discuss how radiotherapy integrates into contemporary options for managing pediatric low-grade glioma.
Register.

Advancing Pediatric ALL Care: Adapting Global Standards for LMICs
2025-12-11
The webinar “Advancing Pediatric ALL Care: Adapting Global Standards for LMICs“ will be held virtually on Thursday, December 11, 2025, at 2 PM CET/Geneva.
This session focuses on sharing Global Updates and Future Directions in pediatric ALL care and specifically addressing how to translate and implement these advancements From Evidence to Practice in Resource-Limited Settings (LMICs), featuring a keynote presentation by Prof. Hiroto Inaba and experience-sharing from SIOP Asia Country Ambassadors.
Register.

BMT Across the World: Who Makes What and Who Pays Whom?
2025-12-11
“BMT Across the World: Who Makes What and Who Pays Whom?” is Part 1 of a joint educational series hosted by the ASTCT (American Society for Transplantation and Cellular Therapy) and the EBMT (European Society for Blood and Marrow Transplantation), scheduled for December 11, 2025, at 9:00 AM CST.
Focusing on allogeneic Bone Marrow Transplantation (BMT), the session aims to explore the significant variations in the clinical, logistical, administrative, and reimbursement landscapes for BMT therapies across different countries. Key topics include how BMT is regulated, implemented, and paid for globally, alongside a critical appraisal of emerging innovations in areas such as GVHD prophylaxis, conditioning regimens, and relapse prevention.
Register.

33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors
2025-12-11 - 2025-12-12 | Oviedo Congress and Exhibitions Center, C. Arturo Álvarez Buylla, Oviedo, Asturias, 33005, Spain
The 33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors is a two-day scientific meeting organized by the TTD Group (Digestive Tumor Treatment Group).
The event will be held from December 11 to December 12, 2025, at the Exhibition and Congress Palace in Oviedo, Spain. The symposium will feature presentations and discussions on the latest advances in treating various digestive tumors.

Best of ESMO India 2025
2025-12-13 - 2025-12-14 | The St. Regis Mumbai, 462 Senapati Bapat Marg, Lower Parel, Mumbai, Maharashtra, 400013, India
The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai, scheduled for December 13–14, 2025.
This conference, hosted by the Global Healthcare Academy (GHA), is a major platform for disseminating the most recent, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress.
Designed for a multidisciplinary audience including medical, surgical, and radiation oncologists, the event will feature focus sessions guided by an extensive advisory, core, and scientific committee comprising leading Indian oncologists, and will be held at The St. Regis Mumbai.
Register.

ESMO Preceptorship on Prostate Cancer 2025: Lugano
2025-12-16 - 2025-12-17 | Lugano, Switzerland
The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management, from diagnosis to treatment, according to current standards of care.
Organized by the European Society for Medical Oncology (ESMO), the event is scheduled to take place on December 16–17, 2025, in Lugano, Switzerland. The preceptorship is designed primarily for medical and clinical oncologists, especially young oncologists, and has been accredited for 9 ESMO-MORA category 1 points.
